In her new report to Congress, National Taxpayer Advocate Erin Collins outlined the 10 biggest challenges taxpayers now face when dealing with the tax agency.
This paper proposes a framework for benchmarking the new product development process of individual companies. The company’s ...
Boehringer Ingelheim has reported encouraging Phase II trial results for apecotrep (BI 764198), a potential first-in-class oral TRPC6 inhibitor being developed for primary focal segmental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results